Cardionovum

Be up
to date.

Latest press release

Late-Breaking Xlimit RCT data presented at CSC Congress demonstrate an equivalent performance of the Xlimus® DES in terms of OCT derived endpoints than the Synergy™ DES.

Bonn, Germany. November 16, 2022 – Data presented at Innovation session today at the CSC 2022 congress demonstrated an equivalent performance of the Xlimus® DES in terms of OCT derived endpoints than the Synergy™ DES, including Neointimal Volume and Neointimal Volume weighted by length at 6 months. Secondary endpoints, including other OCT parameters, such as in-stent Minimum Lumen Area (MLA) and percentage of strut coverage as well as clinical endpoints, showed no significant differences between the two groups in any of the evaluated parameters within the Xlimit RCT.

Learn more >>

Prof. Matteo Tozzi discusses about new data bolster safety and effectiveness of Safepax®

Prof. Matteo Tozzi (Varese, Italy) speaks to Vascular News at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2022 annual meeting in Barcelona (Spain) about his new study that analyzes the concentrations of paclitaxel in the bloodstream after the use of a Drug-Coated Balloons (DCBs) in AVFs.

Learn more >>

CARDIONOVUM® announces regulatory approval of APERTO® OTW in Mexico

We are proud to announce that we have received the authorization by the Secretaria de Salud and COFEPRIS to distribute APERTO® OTW in Mexico.

Learn more >>

Cardionovum® announces First Procedure in Hyper II International Clinical Trial.

CARDIONOVUM® today announced the enrollment of the first patient in the International Hyper II Clinical Study

Learn more >>

CARDIONOVUM® announces the first Signature RCT patient enrollment

On June 8th, in Sankt Gertrauden hospital in Berlin, Germany, the first Signature RCT patient has been enrolled

Learn more >>

CARDIONOVUM announces completion of patients enrolment in XLIMIT Trial

Trial designed to evaluate non inferiority of XLIMUS DES vs SYNERGY EES in terms of reendothelialization assessed with OCT in patients undergoing percutaneous coronary intervention

Learn more >>

Upcoming events

Currently there are no events.

Latest events

New edition of "THE CARDIONOVUM UNIVERSITY"

It is with great pleasure that CARDIONOVUM announces a new edition of “THE CARDIONOVUM UNIVERSITY”.
During this new edition we will concentrate on our Coronary DCB, the RESTORE.

You are kindly invited to participate by clicking here:
https://www.oneviewx.com/event/restore-cardionovum-university-online-webinar/

Date: Dec 03, 2021–Dec 04, 2021

CARDIONOVUM GmbH at the Union Conference

Cardionovum participates in:
21st Union Conference of the Swiss Society for Vascular Diseases

You are cordially invited to visit us at booth no.38.

Location: Interlaken, Switzerland

Date: Dec 01, 2021–Dec 04, 2021

CARDIONOVUM GmbH at IAD

Cardionovum participates in:
9th Annual IAD Conference Interdisciplinary Working Group on Dialysis Access.

We invite you to visit us at booth #7.

Location: Weimar, Germany

Date: Nov 19, 2021–Nov 21, 2021

go top